AXA (AXAHY) Stock Rating Lowered by Zacks Investment Research

AXA (OTCMKTS:AXAHY) was downgraded by Zacks Investment Research from a “hold” rating to a “strong sell” rating in a report issued on Wednesday.

According to Zacks, “The AXA Group is an international group of insurance and related financial services companies. AXA’s insurance operations are diverse geographically, with activities in 50 countries, principally Western Europe, North America and the Asia/Pacific area. In the United States, AXA is represented through its 60% holding in The Equitable companies and its subsidiaries, Equitable Life, Alliance Capital management and Donaldson, Lufkin & Jenrette. “

AXAHY has been the topic of a number of other research reports. ValuEngine downgraded shares of AXA from a “buy” rating to a “hold” rating in a research note on Wednesday, May 2nd. Citigroup downgraded shares of AXA from a “buy” rating to a “neutral” rating in a research note on Tuesday, March 20th.

Shares of AXA traded down $0.53, hitting $24.22, during midday trading on Wednesday, reports. The company had a trading volume of 90,639 shares, compared to its average volume of 178,855. The company has a market cap of $61.10 billion, a price-to-earnings ratio of 8.29, a PEG ratio of 1.28 and a beta of 1.15. The company has a current ratio of 0.08, a quick ratio of 0.08 and a debt-to-equity ratio of 0.11. AXA has a 1-year low of $23.95 and a 1-year high of $33.86.

About AXA

AXA SA, through its subsidiaries, provides insurance and asset management services worldwide. It operates through six segments: France, Europe, Asia, the United States, International, and Transversal and Central Holdings. The company offers a range of insurance products, including life and savings, property and casualty, and health.

Get a free copy of the Zacks research report on AXA (AXAHY)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for AXA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AXA and related companies with's FREE daily email newsletter.

Leave a Reply